# Oric Pharmaceuticals, Inc.: Form 8-K, filed Jun 27, 2023

- Company: [Oric Pharmaceuticals, Inc.](/companies/oric.md) (CIK 1796280)
- Form: 8-K
- Filed: 2023-06-27
- Accepted by EDGAR: Jun 27, 2023, 10:05 ET
- Period: 2023-06-24
- Accession: 0001193125-23-175501
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1796280/000119312523175501/d462067d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1796280/000119312523175501/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1796280/000119312523175501/d462067d8k.htm

Filed Jun 27, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-175501. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
